Lin‐Fen Ding
Impact in
- Rehabilitation top 10%
- Magnolia and Illicium research
-
- Sesquiterpenes and Asteraceae Studies
Papers in
-
- Plant-derived Lignans Synthesis and Bioactivity 10
- Natural product bioactivities and synthesis 9
- Biological Activity of Diterpenoids and Biflavonoids 5
-
- Phytochemistry and Biological Activities 6
- Co-authors
- Xing‐De Wu (29 shared papers)Qin‐Shi Zhao (22 shared papers)Liu‐Dong Song (24 shared papers)Li‐Yan Peng (9 shared papers)Jia Su (4 shared papers)Wei Nie (8 shared papers)Hui Yang (3 shared papers)Juan He (3 shared papers)
- Journals
- Chemistry & Biodiversity (9 papers)Phytochemistry (6 papers)Phytochemistry Letters (6 papers)Journal of Asian Natural Products Research (3 papers)Tetrahedron Letters (2 papers)
- Partner nations
- China
In The Last Decade
Lin‐Fen Ding
32 papers receiving 339 citations
Peers
Comparison fields: 5 of 48
- Rehabilitation 53
- Cancer Research 72
- Complementary and alternative medicine 35
- Pharmacology 60
- Molecular Biology 226
Countries citing papers authored by Lin‐Fen Ding
This map shows the geographic impact of Lin‐Fen Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Fen Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Fen Ding more than expected).
Fields of papers citing papers by Lin‐Fen Ding
This network shows the impact of papers produced by Lin‐Fen Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Fen Ding. The network helps show where Lin‐Fen Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin‐Fen Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 31 | |
| 2 | 2018 | 29 | |
| 3 | 2014 | 25 | |
| 4 | 2009 | 23 | |
| 5 | 2016 | 19 | |
| 6 | 2020 | 16 | |
| 7 | 2021 | 15 | |
| 8 | 2019 | 15 | |
| 9 | 2020 | 15 | |
| 10 | 2017 | 14 | |
| 11 | 2019 | 14 | |
| 12 | 2013 | 12 | |
| 13 | 2013 | 12 | |
| 14 | 2019 | 10 | |
| 15 | 2022 | 10 | |
| 16 | 2016 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2021 | 7 | |
| 19 | 2021 | 7 | |
| 20 | 2021 | 7 |
About Lin‐Fen Ding
Lin‐Fen Ding is a scholar working on Molecular Biology, Plant Science, Organic Chemistry, Rehabilitation and Cancer Research, having authored 36 papers that have together received 344 indexed citations. Recurring topics across this work include Plant-derived Lignans Synthesis and Bioactivity (10 papers), Magnolia and Illicium research (9 papers), Natural product bioactivities and synthesis (9 papers), Sesquiterpenes and Asteraceae Studies (6 papers), Phytochemistry and Biological Activities (6 papers), Biological Stains and Phytochemicals (5 papers), Biological Activity of Diterpenoids and Biflavonoids (5 papers) and Phytochemistry and Bioactive Compounds (4 papers). The work is most often cited by research in Rehabilitation (53 citations), Cancer Research (72 citations), Complementary and alternative medicine (35 citations), Pharmacology (60 citations) and Molecular Biology (226 citations). Lin‐Fen Ding has collaborated with scholars based in China. Frequent co-authors include Xing‐De Wu, Qin‐Shi Zhao, Liu‐Dong Song, Li‐Yan Peng, Jia Su, Wei Nie, Hui Yang, Juan He, Zheng‐Hong Pan and Xiao‐Nian Li. Their work appears in journals such as Chemistry & Biodiversity, Phytochemistry, Phytochemistry Letters, Journal of Asian Natural Products Research and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.